Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Pre-publication history

The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

Dušan Milanović*, Friederike Braun, Wolfgang Weber, Anca Ligia Grosu, Martin Behe and Gabriele Niedermann

BMC Cancer 2012, 12:242  doi:10.1186/1471-2407-12-242

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 17 Jan 2012
Reviewer's Report Dan Duda 09 Feb 2012
Reviewer's Report Bernd Joachim Krause 27 Mar 2012
Resubmission - Version 2 Manuscript Author's comment 07 May 2012
Resubmission - Version 3 Manuscript Author's comment 07 May 2012
Reviewer's Report Dan Duda 21 May 2012
Reviewer's Report Bernd Joachim Krause 24 May 2012
Editorial acceptance 05 Jun 2012
Published 13 Jun 2012